26. Basham TY, Merrigan TC. Recombinant gamma interferon increases HLA-DR 
synthesis and expression. J Immunol 130: 1492-4; 1983. 
27. Livingston PO, Albino A, Chung TSC et al. Serologic response of melanoma 
patients to vaccines prepared from VSV lysates of autologous and allogenic cultured 
melanoma cells. Cancer 55:713-20; 1985. 
28. Livingston PO, Shiku H. Cell-mediated cytotoxicity for cultured autologous 
melanoma cells. Int J Cancer 24:34-44; 1979. 
29. Timonen T, Ortaldo JR, Stadler BM et al. Cultures of purified human natural killer 
cells; growth in the presence of interleukin-2. Cell Immuno 72: 178-85; 1982. 
30. Krown SE. Interferon treatment of renal cell carcinoma: current status and future 
prospects. Cancer 59:647; 1987. 
31. Rosenberg SA. Immunotherapy of patients with advanced cancer using interleukin- 
2 alone or in combination with lymphokine-activated killer cells. DeVita VT, 
Heilman S, and Rosenberg SA (eds.). Important Advances in Oncology 1988 . 
Philadelphia, PA: JP Lippincott, 1988, p.217. 
32. Parkinson DR, Fisher RI, Rayner AA et al. Therapy of renal cell carcinoma with 
interleukin-2 and lymphokine-activated killer cells: phase II experience with a 
hybrid bolus and continuous infusion interleukin-2 regimen. J Clin Oncol 
8: 1630; 1990. 
33. Tepper RI, Pattengal PK, Leder P et al. Murine interleukin-4 displays potent anti- 
tumor activity in vivo. Cell 57:503:1989. 
34. Watanabe Y, Kuribayashi K, Miyatake S et al. Exogenous expression of mouse 
interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced 
tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci USA 
86:9456; 1989. 
35. Asher J, Mul’e JJ, Kasid A et al. Murine tumor cells transduced with the gene for 
tumor necrosis factor-alpha: evidence for paracrine immune effect of tumor 
necrosis factor against tumors. J Immunol 146:3227-34; 1991. 
36. Colombo MP, Ferrari G, Stoppacciaro et al. Granulocyte colony-stimulating factor 
gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J Exp 
Med 173:889-97; 1991. 
37. Cometta K, Moen RC. Amphotropic murine leukemia retrovirus is not an acute 
pathogen for primates. Human Gene Therapy 1:13-26; 1990. 
[ 934 ] 
Recombinant DNA Research, Volume 15 
